Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Amgen | 4.61% | $3.15B | $169.94B | -1.56% | 77 Outperform | |
| Cisco Systems | 4.36% | $2.98B | $280.84B | 22.41% | 79 Outperform | |
| AbbVie | 4.29% | $2.93B | $387.13B | 9.85% | 62 Neutral | |
| Merck & Company | 4.23% | $2.89B | $212.91B | -16.17% | 78 Outperform | |
| Coca-Cola | 4.15% | $2.84B | $297.07B | 10.37% | 78 Outperform | |
| Lockheed Martin | 4.02% | $2.75B | $108.51B | -18.81% | 70 Outperform | |
| Chevron | 4.01% | $2.75B | $313.13B | -1.22% | 74 Outperform | |
| Bristol-Myers Squibb | 3.96% | $2.71B | $94.93B | -13.76% | 69 Neutral | |
| PepsiCo | 3.95% | $2.70B | $193.59B | -13.42% | 78 Outperform | |
| Verizon | 3.78% | $2.58B | $167.90B | -1.11% | 72 Outperform |